Airgas, a nitrogen and oxygen supplier, is considering action against Louisiana over potential misuse of its products during ...
Bioxytran inks non-disclosure agreement with University of Georgia to evaluate Galectin antagonists for bird flu treatment in chickens: Boston Friday, March 21, 2025, 15:00 Hrs [I ...
High-altitude destinations are incredible offering stunning landscapes and unique experiences But they can also push your ...
Nearly a decade ago, what was supposed to be a fun day on the tubing hill in Fraser ended with Stephanie Zavilla suffering a ...
Equities research analysts at William Blair issued their Q1 2025 earnings per share estimates for shares of FibroGen in a research report issued to clients and investors on Tuesday, March 18th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results